Hims & Hers Health Shares Rise Following HHS Announcement on Peptide Compounding
Shares of Hims & Hers Health (HIMS) increased following an announcement from the U.S. Department of Health and Human Services regarding a temporary policy change. The interim guidance allows compounding pharmacies to manufacture several peptides, including popular tissue-repair treatments. This regulatory shift provides a potential pathway for telehealth platforms and specialized pharmacies to offer compounded versions of certain peptide-based medications. The move is expected to impact the availability and accessibility of these treatments in the U.S. market.
Tickers: $HIMS